Branded

STAMFORD, Conn. — Purdue Pharma has new leadership. The company on Thursday named Dr. Craig Landau to the position of president and CEO, effective immediately. He will retain responsibility for Purdue Pharma in Canada as well, and takes over the position in the United States from Mark Timney, who is leaving the company to pursue another opportunity, Purdue said.

IRVINE, Calif. — PrescribeWellness earlier this week announced that their Collaborative Practice Agreement is now available in 19 states across the country. Partner pharmacies in these states can now administer vaccinations without a prescription from a doctor — an important step in reducing the number of adults who are not being properly immunized each year.

SILVER SPRING, Md. — The Food and Drug Administration last week approved Adamis Pharmaceuticals’ Symjepi, a pre-filled dose syringe of epinephrine. The syringe is indicated for emergency treatment of allergic reactions, including anaphylaxis.

WOONSOCKET, R.I. — In an attempt to gauge patients’ attitudes toward the cost of prescription drugs, CVS Health in April conducted a survey of registered voters, whose results the company released Thursday. The survey found that 88% of respondents are somewhat or very concerned about the high cost of prescription drugs.

PHOENIX — The Healthcare Distribution Alliance’s nonprofit HAD Research Foundation has awarded Upsher-Smith Laboratories’ VP partner relations Mike McBride its 2017 Nexus Award for Lifetime Achievement.

The award — which was given by the foundation, alongside Genentech and Mylan at the HDA’s annual Business and Leadership Conference — recognizes character and professional accomplishments, as well as leadership in HDA, the industry and the community.

WASHINGTON — The National Association of Chain Drug Stores and the American Pharmacists Association this week urged the Trump administration to steer clear of legislation that would clear the way for the importation of prescription drugs from other countries.

The two penned a letter calling on Pres. Trump and administration officials to “refrain from endorsing pending legislative proposals that would allow for broad personal and commercial importation of non-[Food and Drug Administration (FDA)] approved prescription drugs.”

DANBURRY, Conn. and RESEARCH TRIANGLE PARK, N.C. — The latest report from the QunitilesIMS Institute is highlighting strides made in oncology therapies and the robust pipeline of forthcoming treatments.

The report, Global Oncology Trends 2017: Advances, Complexity and Cost, notes that 68 novel therapies have been approved globally across 22 cancer indications since 2011, providing more access and better outcomes for patients, particularly those with metastatic cancers.

UMBAI, BALTIMORE and BOISE, Idaho — Albertsons and Lupin Pharmaceuticals announced a new partnership that would bring Lupin’s InspiraChamber to all of Albertsons’ banner pharmacies as the retailer’s preferred inhaled aerosol therapy chamber.

The holding chamber will be available at the more than 1,7000 pharmacies in the 35 states that Albertsons operates, the companies said.